MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3

被引:81
|
作者
Bai, Xiangdong [1 ,3 ]
Han, Guohui [3 ]
Liu, Yang [3 ]
Jiang, Hongchuan [2 ]
He, Qiang [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary Surg, Affiliated Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Dept Breast Surg, Affiliated Hosp, Beijing, Peoples R China
[3] Shanxi Med Univ, Shanxi Prov Canc Hosp, Dept Breast Surg, Taiyuan, Shanxi, Peoples R China
关键词
miR-20a-5p; Triple-negative breast cancer; RUNX3; Cell proliferation; MIR-20A; METASTASIS; INVASION; EXPRESSION; AUTOPHAGY;
D O I
10.1016/j.biopha.2018.04.165
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Increasing evidence showed that microRNAs (miRNAs) were abnormally expressed in cancers and made effects on the tumorigenesis. Aberrant expression of miR-20a-5p has been reported in human breast carcinoma. However, the functional mechanism of miR-20a-5p in human breast carcinoma, particularly in triple-negative breast cancer (TNBC), required further investigations. Here, firstly, we determined that miR-20a-5p was highly expressed in both TNBC tissues and cell lines. Then, we explored that the overexpression of miR-20a-5p promoted the migration and invasion of TNBC cells in vitro. The tendency was significantly reversed after the depletion of miR-20a-5p. Consistent result could be obtained with the in vivo nude mice tumorigenesis. Thirdly, the underlying molecular mechanism was investigated. The Runt-related transcription factor 3 (RUNX3) was identified as a target of miR-20a-5p in TNBC cells. High expression of miR-20a-5p significantly decreased both the mRNA and protein levels of RUNX3, as well as its direct downstream targets Bim and p21. These results verified the significance of miR-20a-5p and explored its functional mechanisms in TNBC, suggesting the potential clinical applications of miR-20a-5p in TNBC.
引用
收藏
页码:1482 / 1489
页数:8
相关论文
共 50 条
  • [31] Research on the effect of interfering with miRNA-155 on triple-negative breast cancer cells
    Hu, Yangying
    Wu, Deqi
    Feng, Xiangjun
    Shi, Zhijie
    GENES & GENOMICS, 2022, 44 (09) : 1117 - 1124
  • [32] Research on the effect of interfering with miRNA-155 on triple-negative breast cancer cells
    Yangying Hu
    Deqi Wu
    Xiangjun Feng
    Zhijie Shi
    Genes & Genomics, 2022, 44 : 1117 - 1124
  • [33] Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
    Tate, Chandra R.
    Rhodes, Lyndsay V.
    Segar, H. Chris
    Driver, Jennifer L.
    Pounder, F. Nell
    Burow, Matthew E.
    Collins-Burow, Bridgette M.
    BREAST CANCER RESEARCH, 2012, 14 (03)
  • [34] Targeting stromal cells to reverse immune suppression in triple-negative breast cancer
    Chen, J.
    Ruan, T.
    Wu, S.
    Lim, E.
    Swarbrick, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S190 - S190
  • [35] Synergistic inhibition of growth of triple-negative breast cancer cells by co-targeting PARP and HDAC
    Marijon, Helene
    Sun, Haibo
    de Gramont, Aimery
    Gery, Sigal
    Koeffler, H. Phillip
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Synthesis of New Chromene Derivatives Targeting Triple-Negative Breast Cancer Cells
    Alneyadi, Aysha
    Nizami, Zohra Nausheen
    Aburawi, Hanan E. E.
    Hisaindee, Soleiman
    Nawaz, Muhammad
    Attoub, Samir
    Ramadan, Gaber
    Benhalilou, Nehla
    Al Azzani, Mazoun
    Elmahi, Yassine
    Almeqbali, Aysha
    Muhammad, Khalid
    Eid, Ali H. H.
    Vijayan, Ranjit
    Iratni, Rabah
    CANCERS, 2023, 15 (10)
  • [37] Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
    Chandra R Tate
    Lyndsay V Rhodes
    H Chris Segar
    Jennifer L Driver
    F Nell Pounder
    Matthew E Burow
    Bridgette M Collins-Burow
    Breast Cancer Research, 14
  • [38] Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
    Shi, Peiguo
    Liu, Wenjing
    Tala
    Wang, Haixia
    Li, Fubing
    Zhang, Hailin
    Wu, Yingying
    Kong, Yanjie
    Zhou, Zhongmei
    Wang, Chunyan
    Chen, Wenlin
    Liu, Rong
    Chen, Ceshi
    CELL DISCOVERY, 2017, 3
  • [39] Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
    Peiguo Shi
    Wenjing Liu
    Haixia Tala
    Fubing Wang
    Hailin Li
    Yingying Zhang
    Yanjie Wu
    Zhongmei Kong
    Chunyan Zhou
    Wenlin Wang
    Rong Chen
    Ceshi Liu
    Cell Discovery, 3
  • [40] Angelicin inhibits the growth and migration of triple-negative breast cancer cells
    Chen, I-hsiao
    Chen, Chien-yu
    Lan, Yu-hsuan
    Chen, I-fen
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (01) : 51 - 58